Longeveron (LGVN) Intangibles (2020 - 2026)
Longeveron's (LGVN) quarterly Intangibles came in at $2.2 million in Q1 2026, down 2.31% year-on-year from $2.3 million in Q1 2025, and down 42.36% quarter-over-quarter from $3.9 million in Q4 2025.
Longeveron (LGVN) Intangibles (2020 - 2026) Analysis & Trends
Longeveron's Intangibles history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Intangibles fell 2.31% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 2.31% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, up 61.72% from the prior year.
- Intangibles eased to $2.2 million in Q1 2026 per LGVN's latest filing, from $3.9 million in the prior quarter.
- Across five years, Intangibles topped out at $3.9 million in Q4 2025 and bottomed at $2.2 million in Q1 2026.
- The 5-year median for Intangibles is $3.2 million (2023), against an average of $3.0 million.
- Across the five-year window, Intangibles surged 206.17% in 2022 and plunged 30.81% in 2024, its largest moves.
- Year by year, Intangibles stood at $2.4 million in 2022, then soared by 32.67% to $3.2 million in 2023, then declined by 24.87% to $2.4 million in 2024, then jumped by 61.72% to $3.9 million in 2025, then plunged by 42.36% to $2.2 million in 2026.
- Per Business Quant, the three latest LGVN Intangibles figures stand at $2.2 million (Q1 2026), $3.9 million (Q4 2025), and $3.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Sep 30, 2025 | 3.82 Mn |
| Jun 30, 2025 | 3.76 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 3.39 Mn |
| Jun 30, 2023 | 3.28 Mn |
| Mar 31, 2023 | 3.17 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 2.93 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1.68 Mn |